|
Q1 FY2027
As of Jun 30, 2026
|
Q4 FY2026
As of Mar 31, 2026
|
Q3 FY2026
As of Dec 31, 2025
|
Q2 FY2026
As of Sep 30, 2025
|
Q1 FY2026
As of Jun 30, 2025
|
Q4 FY2025
As of Mar 31, 2025
|
Q3 FY2025
As of Dec 31, 2024
|
Q2 FY2025
As of Sep 30, 2024
|
Q1 FY2025
As of Jun 30, 2024
|
Q4 FY2024
As of Mar 31, 2024
|
Q3 FY2024
As of Dec 31, 2023
|
Q2 FY2024
As of Sep 30, 2023
|
Q1 FY2024
As of Jun 30, 2023
|
Q4 FY2023
As of Mar 31, 2023
|
Q3 FY2023
As of Dec 31, 2022
|
Q2 FY2023
As of Sep 30, 2022
|
Q1 FY2023
As of Jun 30, 2022
|
Q4 FY2022
As of Feb 28, 2022
|
Q3 FY2022
As of Nov 30, 2021
|
Q2 FY2022
As of Aug 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Prepaid expense | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Prepaid expense and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accounts payable - related parties | ||||||||||||||||||||
| Note payable - related party | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long Term Liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Commitments and Contingencies | ||||||||||||||||||||
| Stockholders' Deficit | ||||||||||||||||||||
| Common stock par value $0.001: 50,000,000 shares authorized; 40,066,951 shares issued and outstanding as of September 30, 2024 and March 31, 2024, respectively | ||||||||||||||||||||
| Common stock par value $0.001: 50,000,000 shares authorized; 40,066,951 shares issued and outstanding as of June 30, 2026 and March 31, 2026 | ||||||||||||||||||||
| Common stock to be issued (357,102 at June 30, 2024 and March 31, 2024, respectively) | ||||||||||||||||||||
| Common stock to be issued (357,102 shares at June 30, 2026 and March 31, 2026) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||||
| Total liabilities and stockholders' deficit | ||||||||||||||||||||
Loading...
